According to Market Research Future (MRFR), the Global pharmacogenomics market is projected to expand at a CAGR of 5.8% over the forecast period (2017-2023).
Market Drivers and Top Barriers
The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising focus on precision medicine coupled with the growing ... Read more
According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025). ... Read more
Pharmacogenomics is a relatively new field of study which is a combination of genomics and pharmacology. It studies how based on genes, a person reacts to drugs which aid in the development of more effective and safe medications. With Pharmacogenomics, drug doses can be tailored to a person's genetic makeup and can be useful in the treatment of a wide range of health problems. The Global ... Read more
According to Market Research Future (MRFR), the Global Pharmacogenomics Testing Market is Projected to Expand at a CAGR of 5.8% Over the Forecast Period (2019-2023).
The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising ... Read more
Pharmacogenomics or Pharmacogenetics is a study that refers to the genes and their impact on the way human body responses to the medication. The study combines pharmacology, the science of medicines and genomics, the study of genes and their functions to develop effective, safe drugs and doses, personalized for a typical genetic makeup (person’s genetic structure). The key objective of this study is to help doctors to pick the best- ... Read more
A) Market Overview:
Pharmacogenomics is the study of how a person's genetic makeup affects their response to drugs. It involves analyzing a patient's DNA to determine their likelihood of responding to a particular medication. This information can then be used to personalize the treatment plan and optimize drug effectiveness. Pharmacogenomics has gained significant popularity in recent years due to its potential to improve patient outcomes and reduce adverse ... Read more
The Pharmacogenomics Market is estimated to be valued at US$14,028.01 million in 2023 and is expected to exhibit a CAGR of 11.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pharmacogenomics is the study of how a person's genetic makeup affects their response to drugs. The aim of pharmacogenomics is to develop personalized medicine that is specifically ... Read more
The pharmacogenomics market is estimated to be valued at US$ 33079.39 Mn in 2023 and is expected to exhibit a CAGR of 11.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pharmacogenomics is a science that studies how genes affect individual's response to drugs. It analyses how inherited genetic differences influence drug response. ... Read more
Pharmacogenomics refers to a scientific approach used to study how genes affect individual responses to drug therapies. With the help of pharmacogenomics, researchers can develop targeted drugs and therapies customized according to an individual's unique genetic makeup and personal characteristics. Such customized drugs help optimize medical treatment through personalized medicines by determining the right dose for the right patient at the right time, thereby improving therapeutic efficacy ... Read more
The pharmacogenomics market involves the use of genomic information to guide prescription drug therapies. Pharmacogenomics is playing a key role in improving patient outcomes for treatment of various diseases like cancer, infectious diseases, neurological disorders and cardiovascular diseases. Molecular diagnostics are increasingly being adopted for genetic testing prior to prescribing drugs in order to avoid adverse drug reactions and determine optimal dosages based on a person's genetic ... Read more
